Company Filing History:
Years Active: 2024
Title: Innovations of Satish S Jalisatgi in Neuromuscular Blocking Agents
Introduction
Satish S Jalisatgi is an accomplished inventor based in Columbia, MO (US). He has made significant contributions to the field of pharmacology, particularly in the development of neuromuscular blocking agents. His innovative work has the potential to impact medical practices and enhance patient care.
Latest Patents
Satish S Jalisatgi holds a patent for neuromuscular blocking agents. The patent discloses carborane derivatives of Formula I or Formula V, or a pharmaceutically acceptable salt thereof, for use as neuromuscular blocking agents. The carborane is uniquely substituted with two cationic functional groups selected from amines that form ammonium cations, ethers and/or alcohols that form oxonium cations, sulfides and/or thiols that form sulfonium cations, and phosphanes and/or phosphines that form phosphonium cations. This innovative approach may lead to more effective treatments in clinical settings.
Career Highlights
Satish S Jalisatgi is affiliated with the University of Missouri, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and excellence in the field of pharmacology.
Collaborations
He has collaborated with notable colleagues, including George R Kracke and Lalit N Goswami. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Satish S Jalisatgi's contributions to the field of neuromuscular blocking agents exemplify the importance of innovation in medicine. His work not only advances scientific knowledge but also holds promise for improving patient outcomes.